Literature DB >> 34311753

Incidence trends and survival prediction of urothelial cancer of the bladder: a population-based study.

Hairong He1,2, Tianjie Liu3, Didi Han2, Chengzhuo Li2, Fengshuo Xu2, Jun Lyu2,4, Ye Gao5.   

Abstract

BACKGROUND: The aim of this study is to determine the incidence trends of urothelial cancer of the bladder (UCB) and to develop a nomogram for predicting the cancer-specific survival (CSS) of postsurgery UCB at a population-based level based on the SEER database.
METHODS: The age-adjusted incidence of UCB diagnosed from 1975 to 2016 was extracted, and its annual percentage change was calculated and joinpoint regression analysis was performed. A nomogram was constructed for predicting the CSS in individual cases based on independent predictors. The predictive performance of the nomogram was evaluated using the consistency index (C-index), net reclassification index (NRI), integrated discrimination improvement (IDI), a calibration plot and the receiver operating characteristics (ROC) curve.
RESULTS: The incidence of UCB showed a trend of first increasing and then decreasing from 1975 to 2016. However, the overall incidence increased over that time period. The age at diagnosis, ethnic group, insurance status, marital status, differentiated grade, AJCC stage, regional lymph nodes removed status, chemotherapy status, and tumor size were independent prognostic factors for postsurgery UCB. The nomogram constructed based on these independent factors performed well, with a C-index of 0.823 and a close fit to the calibration curve. Its prediction ability for CSS of postsurgery UCB is better than that of the existing AJCC system, with NRI and IDI values greater than 0 and ROC curves exhibiting good performance for 3, 5, and 8 years of follow-up.
CONCLUSIONS: The nomogram constructed in this study might be suitable for clinical use in improving the clinical predictive accuracy of the long-term survival for postsurgery UCB.
© 2021. The Author(s).

Entities:  

Keywords:  Incidence; Nomogram; Survival; Urothelial cancer of the bladder

Year:  2021        PMID: 34311753     DOI: 10.1186/s12957-021-02327-x

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  32 in total

Review 1.  Bladder cancer: epidemiology, staging and grading, and diagnosis.

Authors:  Ziya Kirkali; Theresa Chan; Murugesan Manoharan; Ferran Algaba; Christer Busch; Liang Cheng; Lambertus Kiemeney; Martin Kriegmair; R Montironi; William M Murphy; Isabell A Sesterhenn; Masaaki Tachibana; Jeff Weider
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

Review 2.  Bladder Cancer: Diagnosis and Treatment.

Authors:  Katharine C DeGeorge; Harry R Holt; Stephanie C Hodges
Journal:  Am Fam Physician       Date:  2017-10-15       Impact factor: 3.292

3.  Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort.

Authors:  Damien Pouessel; Sylvie Bastuji-Garin; Nadine Houédé; Dimitri Vordos; Yohann Loriot; Christine Chevreau; Emmanuel Sevin; Philippe Beuzeboc; Alexandre de la Taille; Aurélie Le Thuaut; Yves Allory; Stéphane Culine
Journal:  Clin Genitourin Cancer       Date:  2016-07-21       Impact factor: 2.872

4.  Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naïve stage T1 high-grade urothelial bladder cancer.

Authors:  Wolfgang Otto; Bas Wg van Rhijn; Johannes Breyer; Simone Bertz; Markus Eckstein; Roman Mayr; Eva M Lausenmeyer; Stefan Denzinger; Maximilian Burger; Arndt Hartmann
Journal:  Int J Urol       Date:  2018-02-22       Impact factor: 3.369

5.  Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients.

Authors:  Markus Eckstein; Rudolf Jung; Katrin Weigelt; Danijel Sikic; Robert Stöhr; Carol Geppert; Abbas Agaimy; Verena Lieb; Arndt Hartmann; Bernd Wullich; Sven Wach; Helge Taubert
Journal:  Sci Rep       Date:  2018-12-06       Impact factor: 4.379

Review 6.  Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis.

Authors:  Radosław Piszczek; Łukasz Nowak; Wojciech Krajewski; Joanna Chorbińska; Sławomir Poletajew; Marco Moschini; Krzysztof Kaliszewski; Romuald Zdrojowy
Journal:  World J Surg Oncol       Date:  2021-04-21       Impact factor: 2.754

Review 7.  Emerging therapeutic targets in bladder cancer.

Authors:  Benedito A Carneiro; Joshua J Meeks; Timothy M Kuzel; Mariana Scaranti; Sarki A Abdulkadir; Francis J Giles
Journal:  Cancer Treat Rev       Date:  2014-11-24       Impact factor: 13.608

8.  The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China.

Authors:  Sheng Xu; Gui-Ming Zhang; Feng-Ju Guan; Da-Hai Dong; Lei Luo; Bin Li; Xiao-Cheng Ma; Jun Zhao; Li-Jiang Sun
Journal:  World J Surg Oncol       Date:  2015-08-07       Impact factor: 2.754

9.  Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer.

Authors:  Lin Yao; Kunlin Yang; Xuesong Li; Zheng Zhang; Cuijian Zhang; Kan Gong; Zhijun Xi; Zhisong He; Liqun Zhou
Journal:  World J Surg Oncol       Date:  2016-06-28       Impact factor: 2.754

Review 10.  The global burden of urinary bladder cancer: an update.

Authors:  Anke Richters; Katja K H Aben; Lambertus A L M Kiemeney
Journal:  World J Urol       Date:  2019-11-01       Impact factor: 4.226

View more
  2 in total

1.  Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.

Authors:  Jingchao Liu; Zhipeng Zhang; Xiaodong Liu; Wei Zhang; Lingfeng Meng; Jiawen Wang; Zhengtong Lv; Haoran Xia; Yaoguang Zhang; Jianye Wang
Journal:  World J Surg Oncol       Date:  2022-02-24       Impact factor: 2.754

2.  Clinical Outcomes and Prognosis Analysis of Younger Bladder Cancer Patients.

Authors:  Mierxiati Abudurexiti; Jie Ma; Yao Li; Chuanyi Hu; Zhikang Cai; Zhong Wang; Ning Jiang
Journal:  Curr Oncol       Date:  2022-01-28       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.